KromaTiD

BiotechnologySeries CLongmont, USkromatid.com

Latest round

Series C

Last raised

Jul 2025

Total raised

$9.3M

Investors

2

About KromaTiD

KromaTiD, Inc. specializes in genomic integrity analysis, providing innovative solutions for single-cell visualization and reporting through their proprietary KROMASURE™ Platform, crucial for advancing cell and gene therapy research. Founded in 2007, KromaTiD, Inc. is based in Longmont, US, focusing on genomic integrity analysis. In August 2025, KromaTiD, Inc. KromaTiD specializes in genomic integrity analysis, focusing on single-cell visualization through its KROMASURE™ Platform.KromaTiD's revenue model is driven by B2B transactions, offering services and solutions to biotech firms, pharmaceutical companies, and regulatory bodies. The company engages clients through partnerships that grant access to the KROMASURE™ Platform and genomic analysis services, with a pricing structure that includes project-based fees and subscription models tailored to client needs.

Who invested in KromaTiD

2 investors across 2 rounds

See all investors in KromaTiD

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series C

    Jul 1, 2025

    Amount

    $1.5M

    Investors

    Locked

  2. Series A

    Sep 30, 2021

    Amount

    $7.9M

    Investors

    Locked

Questions about KromaTiD

Who invested in KromaTiD?

KromaTiD has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has KromaTiD raised?

KromaTiD has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did KromaTiD last raise money?

KromaTiD's most recent round on record is a Series C, in Jul 2025.

What does KromaTiD do?

KromaTiD is a biotechnology company.

Where is KromaTiD headquartered?

KromaTiD is headquartered in Longmont, US.

Which VCs invest in companies like KromaTiD?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at KromaTiD's stage. Their profiles are linked below.

Raising like KromaTiD? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.